Upper Airway Myopathy is Important in the Pathophysiology of Obstructive Sleep Apnea
2007; American Academy of Sleep Medicine; Volume: 03; Issue: 06 Linguagem: Inglês
10.5664/jcsm.26964
ISSN1550-9397
Autores Tópico(s)Voice and Speech Disorders
ResumoFree AccessPhysiologyUpper Airway Myopathy is Important in the Pathophysiology of Obstructive Sleep Apnea R. John Kimoff, M.D. R. John Kimoff, M.D. Address correspondence to: Dr J. Kimoff, Respiratory Division, Room L4.08, McGill University Health Centre, 687 Pine Ave. W, Montreal, Quebec, Canada, H3A 1A1(514) 934-1934, Ext: 36117(514) 843-1695 E-mail Address: [email protected] Respiratory Division and Sleep Laboratory, McGill University Health Centre and Meakins-Christie Laboratories, McGill University, Montreal, Canada Published Online:October 15, 2007https://doi.org/10.5664/jcsm.26964Cited by:33SectionsPDF ShareShare onFacebookTwitterLinkedInRedditEmail ToolsAdd to favoritesDownload CitationsTrack Citations AboutINTRODUCTIONIn this article, the term "myopathy" will encompass any process which adversely impacts on upper airway muscle force generation and resultant tissue displacement. Key evidence which supports a role for upper airway myopathy in the pathophysiology of OSA will be highlighted.OSA is associated with changes in contractile function of upper airway dilator muscles. In order to adapt to increased contractile demands, skeletal muscle fiber phenotype can undergo modification from a shift from oxidative slow-twitch, fatigue resistant Type I, to glycolytic fast-twitch Type II fibers, which generate increased force but are more prone to fatigue. Several groups have evaluated upper airway muscle histological, biochemical and in vitro contractile properties in OSA. Series et al 1–3 studied musculus uvulae and found an increased proportion of fast-twitch type IIa fibers along with augmented levels of enzymes associated with anaerobic metabolism in OSA patients vs. snorers1. An increase in type IIa fiber prevalence was also found in the genioglossus muscle of OSA patients2. Contractile characteristics of musculus uvulae but not genioglossus were studied in vitro1–3. Force generation was slightly higher for musculus uvulae in OSA than control1,3 but muscle fatigability showed a nonsignificant tendency to be greater in OSA patients1. Smirne et al4 also reported a type IIa fiber shift. Carrera et al5,6 studied the characteristics of genioglossus in OSA patients vs controls and reported a type II fiber shift, and showed preserved tetanic force generation, but in nonobese OSA patients, clearly increased muscle fatigability. Changes similar to those in humans have been reported in animal models. Petrof et al7 reported Type II fiber shifts in the sternohyoid and geniohyoid muscles in the English bulldog, a spontaneous model of OSA. In the rat, both short- and longer-term intermittent hypoxia8,9 have been reported to produce type II fiber shifts, preserved contractility, but increased fatigability of geniohyoid and sternohyoid muscles. Thus a theme emerges that upper airway muscle loading and/or hypoxia in OSA leads to shifts to fast-twitch but more fatigue-prone fiber types, and that in vitro muscle contractility is preserved or even slightly increased but at the cost of increased fatigability, i.e. a reduced ability to sustain force generation with repeated stimulation. While these changes likely represent an adaptive response to increased upper airway loading,10 there is a high likelihood that in vivo, the increased susceptibility to fatigue could lead to a progressive loss of force generation, muscle shortening and tissue displacement by upper airway dilators during the repeated high-level activation required to restore airway patency7,10. Indeed, in vivo changes in muscle function with recurrent apneas could be a contributing factor to the progression of OSA severity across the night that we have previously reported11,12. There is evidence for dysfunctional mechanical coupling of upper airway muscles in OSA, which attenuates the tissue displacement resulting from dilator muscle contraction. In an important study, Series and colleagues3 measured the elastance of uvular tissue (which incorporated the musculus uvulae). They found that uvular elastance was increased in OSA patients, such that the degree of shortening of intact uvular tissue specimens for a given force of stimulated muscle contraction was significantly less than for nonapneic controls. They subsequently dissected out the musculus uvulae and demonstrated that muscle force generation per se was again slightly greater for OSA than control1,3. Thus even if the force generating capacity of the upper airway dilator muscles is preserved, the effects of muscle activation on tissue displacement in OSA are significantly reduced, likely due to connective tissue alterations3. This would therefore be expected to attenuate the effects on upper airway patency of dilator muscle activation. There is strong evidence for upper airway dilator muscle denervation in OSA patients, which would impair muscle contractile function in vivo. We have described an oropharyngeal sensory impairment in OSA13–15 which has been confirmed by others16,17 and which is partially reversible with CPAP13. We have also identified a similar impairment at the laryngeal level which correlates with OSA severity.14,15 Woodson et al18 described nerve demyelination in upper airway tissue, and Friberg et al19 reported changes in upper airway mucosal nerve endings consistent with a pattern of injury and repair. These findings support the presence of an upper airway sensory neuropathy in OSA, which is proposed to be due to mechanical trauma associated with snoring and apneas (vibration, tissue traction, etc.) during obstructive events, oxidative stress related to hypoxia-reoxygenation, and inflammation related to both of these factors.13–15,20–22 There is every reason to believe that this neuropathic process would not be isolated to sensory nerves, but would also affect motor nerves, and thereby lead to muscle denervation. Indeed, there is growing morphologic and physiologic evidence for upper airway muscle denervation in OSA. Immunohistochemical studies from several groups have demonstrated classic findings of muscle denervation including characteristic fiber type grouping, grouped atrophy, and increased fiber size variability (fiber atrophy and hypertrophy),20,23–25 particularly in palatal muscle specimens obtained from OSA patients as compared with control. Our laboratory has provided further immunohistochemical evidence for ongoing, active denervation in OSA palatal muscle in that we identified increased expression of Neural Cell Adhesion Molecule, a subsarcolemmal protein which is transiently expressed in denervated muscle cells.21 There is also physiologic evidence for upper airway muscle denervation in OSA. Svanborg has described a high prevalence of characteristic denervation potentials in palatal muscles of OSA patients.20 More recently, an increase has been observed in OSA patients vs. controls in the area and duration of single motor unit action potentials recorded in genioglossus during quiet breathing (Gandevia, Saboisky, and colleagues, unpublished observations). These findings are characteristic for denervation. There is therefore compelling morphologic and physiologic evidence for denervation changes in key upper airway dilator muscles in OSA. The issue of denervation myopathy is of considerable potential importance with respect to in vivo upper airway contractile function. The in vitro human studies of Series et al1–3 and Carrera et al,5,6 which assessed contractility of musculus uvulae and genioglossus, did so using standard protocols of stimulation via wire electrodes of muscle strips in a bath. This approach will activate all muscle fibers, whether innervated or denervated. While electrically stimulated force generation was found to be similar in OSA and control muscle, the situation in vivo could be very different. In vivo, muscle contraction would be dependent on endogenous neurogenic activation—i.e., activation by the diseased nerves supplying the muscle rather than stimulating electrodes—which would be expected to be much less efficient in the presence of motor neuropathy, and in particular would preclude activation of denervated muscle fibers. Thus the in vitro contractility studies referred to above cannot be taken as conclusive evidence for normal muscle force generation by upper airway dilator muscles in vivo. The observations concerning denervation myopathy, together with the evidence for increased fatigability and dysfunctional mechanical coupling of upper airway dilators discussed above, provide compelling support for the concept of impaired in vivo upper airway dilator muscle contractile function in OSA. There is histologic evidence for other upper airway myopathic changes in OSA. Petrof et al7 reported abnormal fiber morphology (central nucleation, fissured and moth-eaten appearance), inflammatory cell infiltrates, and increased connective tissue in sternohyoid and geniohyoid in the English bulldog. These changes were attributed to muscle overuse and injury due to upper airway loading,7,10 as well as to eccentric contraction which may occur during airway occlusion.26 Findings in human tissue studies have been discrepant, with some authors reporting grossly normal muscle histology1,2,5 while others have described changes similar to those in the bulldog.18,21,24,27 These disparate findings likely stem from differences in the muscles sampled, pathologic techniques, and patient characteristics, but also suggest that the extent of myopathic change varies between individuals. However, when present, pathologic changes of the nature described are undoubtedly associated with impaired force generation. OSA is known to occur in clinical conditions involving pharyngeal neuromuscular dysfunction. Examples of this include the high prevalence of sleep apnea reported in Charcot-Marie-Tooth disease, a condition characterized by peripheral sensory and motor neuropathy.28 OSA severity was correlated with the severity of changes in motor nerve conduction, suggesting that neurogenic upper airway myopathy may contribute to OSA. More recently, oculopharyngeal muscular dystrophy, which selectively affects the extraocular and pharyngeal muscles, was reported to be associated with OSA in the absence of obesity or abnormal upper airway morphology.29 These observations suggest that a clinically identified myopathy can be associated with upper airway collapse which occurs uniquely during sleep, resulting in OSA. The concept of an upper airway myopathy is entirely consistent with other current data on OSA pathophysiology. A fundamental observation is that, while upper airway dimensions are reduced during wakefulness in OSA, complete upper airway closure occurs only during sleep. Upper airway muscle EMG activity is increased during wakefulness in OSA, which is interpreted as indicating increased drive to, and force generation by, upper airway dilators to compensate for reduced anatomic dimensions.30,31 When loss of waking tonic and phasic respiratory drive and attenuation of protective airway reflexes occurs at sleep onset, this is believed to result in inadequate dilator muscle compensation for reduced airway size, and complete collapse ensues.31 The concept of upper airway muscle dysfunction is entirely consistent with the other aspects of this schema. It is well established that EMG amplitude cannot necessarily be equated with muscle force generation, shortening, or tissue displacement.32,33 Changes in excitation-contraction coupling can occur such that EMG amplitude can be maintained or even increase as force generation wanes in fatiguing or myopathic muscle.32,33 Therefore, the augmented EMG activity described during wakefulness in OSA may reflect increased drive to upper airway muscles but does not necessarily indicate commensurately increased muscle force generation. Indeed, the fact that despite increased EMG activity, upper airway dimensions remain reduced during wakefulness in OSA strongly suggests inefficient muscle force generation (i.e., is consistent with myopathy). With sleep onset, the reduction in drive to upper airway muscles could result in airway collapse, in part due to the fact that the inefficient force generation and tissue displacement by myopathic muscles are no longer adequate at the reduced level of drive to compensate for airway size and collapsibility. Through this mechanism, therefore, an upper airway myopathy could contribute to complete airway collapse, which occurs only during sleep. Consistent with this, at least one study34 indicates that in mild forms of OSA, upper airway muscle training may reduce the number of respiratory events during sleep. Thus an increase in overall muscle force generating capacity and/or endurance due to training during wakefulness may lead to a beneficial impact on preservation of upper airway patency during sleep. In summary, there is considerable evidence pointing to altered upper airway muscle contractile function in OSA and its role in the pathophysiology of this disorder. On the basis of the arguments presented here, we believe that to fail to pursue further investigation in this area, would be to ignore an important disease mechanism and perhaps even an eventual therapeutic target in this condition.Disclosure statementThis was not an industry supported study. The author has indicated no financial conflicts of interest.REFERENCES1 Series F , Cote C , Simoneau J-A , et al.Physiologic, metabolic, and muscle fiber type characteristics of musculus uvulae in sleep apnea hypopnea syndrome and in snorersJ Clin Invest199595205, 7814616 CrossrefGoogle Scholar2 Series F , Simoneau J-A , St. Pierre S , Marc ICharacteristics of the genioglossus and musculus uvulae in sleep apnea hypopnea syndrome and in snorersAm J Respir Crit Care Med199615318704, 8665048 CrossrefGoogle Scholar3 Series F , Cote C , St Pierre SDysfunctional mechanical coupling of upper airway tissues in sleep apnea syndromeAm J Respir Crit Care Med19991595Pt 115515, 10228125 CrossrefGoogle Scholar4 Smirne S , Iannaccone S , Ferini-Strambi L , Comola M , Colombo E , Nemni RMuscle fibre type and habitual snoringLancet19913375979, 1671953 CrossrefGoogle Scholar5 Carrera M , Barbé F , Sauleda J , Tomás M , Gómez C , Agustí AGNPatients with obstructive sleep apnea exhibit genioglossus dysfunction that is normalized after treatment with continuous positive airway pressureAm J Respir Crit Care Med199915919606, 10351945 CrossrefGoogle Scholar6 Carrera M , Barbe F , Sauleda J , et al.Effects of obesity upon genioglossus structure and function in obstructive sleep apnoeaEur Respir J2004234259, 15065833 CrossrefGoogle Scholar7 Petrof BJ , Pack AI , Kelly AM , Eby J , Hendricks JCPharyngeal myopathy of loaded upper airway in dogs with sleep apneaJ Appl Physiol199476174652, 8045855 CrossrefGoogle Scholar8 Pae EK , Wu J , Nguyen D , Monti R , Harper RMGeniohyoid muscle properties and myosin heavy chain composition are altered after short-term intermittent hypoxic exposureJ Appl Physiol20059888994, 15557011 CrossrefGoogle Scholar9 Bradford A , McGuire M , O'Halloran KDDoes episodic hypoxia affect upper airway dilator muscle function? Implications for the pathophysiology of obstructive sleep apnoeaRespir Physiol Neurobiol200514722334, 16087148 CrossrefGoogle Scholar10 Petrof BJ , Hendricks JC , Pack AIMuscle factors in obstructive sleep apneaSleep apnea: pathogenesis, diagnosis, and treatment2002New York, NYMarcel Dekker21734 Google Scholar11 Charbonneau M , Martin JM , Olha AE , Kimoff RJ , Levy RD , Cosio MGChanges in obstructive sleep apnea characteristics across the nightChest19941061695701, 7988186 CrossrefGoogle Scholar12 Montserrat JM , Kosmas E , Cosio MG , Kimoff RJMechanism of apnea lengthening across the night in obstructive sleep apneaAm J Respir Crit Care Med199615498893, 8887596 CrossrefGoogle Scholar13 Kimoff RJ , Sforza E , Champagne V , Ofiara L , Gendron DUpper airway sensation in snoring and obstructive sleep apneaAm J Respir Crit Care Med20011642505, 11463596 CrossrefGoogle Scholar14 Nguyen AT , Jobin V , Payne R , Beauregard J , Naor N , Kimoff RJLaryngeal and velopharyngeal sensory impairment in obstructive sleep apneaSleep20052858593, 16171271 CrossrefGoogle Scholar15 Payne RJ , Kost KM , Frenkiel S , et al.Laryngeal inflammation assessed using the reflux finding score in obstructive sleep apneaOtolaryngol Head Neck Surg200613483642, 16647544 CrossrefGoogle Scholar16 Guilleminault C , Li K , Chen NH , Poyares DTwo-point palatal discrimination in patients with upper airway resistance syndrome, obstructive sleep apnea syndrome, and normal control subjectsChest200212286670, 12226025 CrossrefGoogle Scholar17 Dematteis M , Levy P , Pepin JLA simple procedure for measuring pharyngeal sensitivity: a contribution to the diagnosis of sleep apnoeaThorax20056041826, 15860719 CrossrefGoogle Scholar18 Woodson BT , Garancis JC , Toohill RJHistopathologic changes in snoring and obstructive sleep apnea syndromeLaryngoscope1991101131822, 1766303 CrossrefGoogle Scholar19 Friberg D , Gazelius B , Hokfelt T , Nordlander BAbnormal afferent nerve endings in the solft palatal mucosa of sleep apnoics and habitual snorersRegul Pept1997712936, 9299639 CrossrefGoogle Scholar20 Svanborg EImpact of obstructive apnea syndrome on upper airway respiratory musclesRespir Physiol Neurobiol200514726372, 16054444 CrossrefGoogle Scholar21 Boyd JH , Petrof BJ , Hamid Q , Fraser R , Kimoff RJUpper airway muscle inflammation and denervation changes in obstructive sleep apneaAm J Respir Crit Care Med20041705416, 15151922 CrossrefGoogle Scholar22 Bergeron C , Kimoff J , Hamid QObstructive sleep apnea syndrome and inflammationJ Allergy Clin Immunol200511613936, 16337480 CrossrefGoogle Scholar23 Friberg D , Ansved T , Borg K , Carlsson-Nordlander B , Larsson H , Svanborg EHistological indications of a progressive snorers disease in an upper airway muscleAm J Respir Crit Care Med199815758693, 9476877 CrossrefGoogle Scholar24 Edstrom L , Larsson H , Larsson LNeurogenic effects on the palatopharyngeal muscle in patients with obstructive sleep apneaJ Neurol Neurosurg Psych19925591620 CrossrefGoogle Scholar25 Lindman R , Stahl PSAbnormal palatopharyngeal muscle morphology in sleep-disordered breathingJ Neurol Sci20021951123, 11867069 CrossrefGoogle Scholar26 van Lunteren E , Haxhiu MA , Cherniack NSEffects of tracheal airway occlusion on hyoid muscle length and upper airway volumeJ Appl Physiol19896722962302, 2606835 CrossrefGoogle Scholar27 Ferini-Strambi LJ , Smirne S , Moz U , Sferrazza B , Iannaccone SMuscle fibre type and obstructive sleep apneaSleep Res Online19981247, 11382854 Google Scholar28 Dematteis M , Pepin JL , Jeanmart M , Deschaux C , Labarre-Vila A , Levy PCharcot-Marie-Tooth disease and sleep apnoea syndrome: a family studyLancet200135726772, 11214130 CrossrefGoogle Scholar29 Dedrick DL , Brown LKObstructive sleep apnea syndrome complicating oculopharyngeal muscular dystrophyChest200412533436, 14718463 CrossrefGoogle Scholar30 Mezzanotte WS , Tangel DJ , White DPWaking genioglossal EMG in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism)J Clin Invest19928915719, 1569196 CrossrefGoogle Scholar31 Fogel RB , Malhotra A , White DPSleep. 2: Pathophysiology of obstructive sleep apnoea/hypopnoea syndromeThorax20045915963, 14760159 CrossrefGoogle Scholar32 Basmajian JV , De Luca CMuscles alive: their functions revealed by electromyography19855th ed.BaltimoreWilliams – Wilkins Google Scholar33 Roussos C , Moxham J , Roussos C , Macklem PTRespiratory muscle fatigueThe Thorax, Part B1985New YorkMarcel Dekker82970 Google Scholar34 Puhan MA , Suarez A , Lo CC , Zahn A , Heitz M , Braendli ODidgeridoo playing as alternative treatment for obstructive sleep apnoea syndrome: randomised controlled trialBMJ200633226670, 16377643 CrossrefGoogle Scholar Previous article Next article FiguresReferencesRelatedDetailsCited by An Oral Myofunctional Exercise Prescription For Obstructive Sleep ApneaSechser N, Overhue H and Van Guilder G ACSM'S Health & Fitness Journal, 10.1249/FIT.0000000000000670, Vol. 25, No. 3, (35-43), Online publication date: 1-May-2021. Obstructive sleep apnea in children with hypothalamic obesity: Evaluation of possible related factorsIyigun I, Alikasifoglu A, Gonc N, Ozon A, Eryilmaz Polat S, Hizal M, Kiper N and Ozcelik U Pediatric Pulmonology, 10.1002/ppul.25097 Muscle type of palatopharyngeal muscle in children with severe obstructive sleep apneaChen H, Huang X, Ye Y, Luo Y, Huang Y and Li X Journal of Clinical Sleep Medicine, Vol. 16, No. 9, (1523-1529), Online publication date: 15-Sep-2020. A Guide to Management of Sleepiness in ESKDSo J, Warburton K and Rosen I American Journal of Kidney Diseases, 10.1053/j.ajkd.2019.09.010, Vol. 75, No. 5, (782-792), Online publication date: 1-May-2020. Effects of inhaled fluticasone propionate on extrinsic tongue muscles in ratsSetzke C, Broytman O, Russell J, Morel N, Sonsalla M, Lamming D, Connor N and Teodorescu M Journal of Applied Physiology, 10.1152/japplphysiol.00359.2019, Vol. 128, No. 3, (576-585), Online publication date: 1-Mar-2020. Desmin and dystrophin abnormalities in upper airway muscles of snorers and patients with sleep apneaShah F, Franklin K, Holmlund T, Levring Jäghagen E, Berggren D, Forsgren S and Stål P Respiratory Research, 10.1186/s12931-019-0999-9, Vol. 20, No. 1, Online publication date: 1-Dec-2019. Analysis of patients with obstructive sleep apnea with and without pharyngeal myopathy using brain neuroimagingBaima C, Fim N, Alves K, Resende L, Fonseca R and Betting L Sleep, 10.1093/sleep/zsz216, Neurotrophic factor BDNF is upregulated in soft palate muscles of snorers and sleep apnea patientsShah F, Forsgren S, Holmlund T, Levring Jäghagen E, Berggren D, Franklin K and Stål P Laryngoscope Investigative Otolaryngology, 10.1002/lio2.225, Vol. 4, No. 1, (174-180), Online publication date: 1-Feb-2019. Axon and Schwann Cell Degeneration in Nerves of Upper Airway Relates to Pharyngeal Dysfunction in Snorers and Patients With Sleep ApneaShah F, Holmlund T, Levring Jäghagen E, Berggren D, Franklin K, Forsgren S and Stål P Chest, 10.1016/j.chest.2018.06.017, Vol. 154, No. 5, (1091-1098), Online publication date: 1-Nov-2018. Neuropathic changes in the tongue protruder muscles in patients with snoring or obstructive sleep apneaPodnar S and Dolenc Grošelj L Neurophysiologie Clinique, 10.1016/j.neucli.2018.05.040, Vol. 48, No. 5, (269-275), Online publication date: 1-Oct-2018. Sex, stress and sleep apnoea: Decreased susceptibility to upper airway muscle dysfunction following intermittent hypoxia in femalesO'Halloran K, Lewis P and McDonald F Respiratory Physiology & Neurobiology, 10.1016/j.resp.2016.11.009, Vol. 245, , (76-82), Online publication date: 1-Nov-2017. Chronic intermittent hypoxia creates the perfect storm with calamitous consequences for respiratory control.O'Halloran K Respiratory Physiology & Neurobiology, 10.1016/j.resp.2015.10.013, Vol. 226, , (63-67), Online publication date: 1-Jun-2016. Kimoff R Obstructive Sleep Apnea Murray and Nadel's Textbook of Respiratory Medicine, 10.1016/B978-1-4557-3383-5.00088-9, (1552-1568.e9), . Obstructive Sleep Apnea and Kidney Disease: A Potential Bidirectional Relationship?Abuyassin B, Sharma K, Ayas N and Laher I Journal of Clinical Sleep Medicine, Vol. 11, No. 08, (915-924), Online publication date: 15-Aug-2015. Neurogenic Changes in the Upper Airway of Obstructive Sleep ApnoeaSaboisky J, Butler J, Luu B and Gandevia S Current Neurology and Neuroscience Reports, 10.1007/s11910-015-0537-1, Vol. 15, No. 4, Online publication date: 1-Apr-2015. Obstructive sleep apnea in patients with rheumatoid arthritis: Correlation with disease activity and pulmonary function testsFouda N and Dayem A The Egyptian Rheumatologist, 10.1016/j.ejr.2014.04.002, Vol. 36, No. 4, (165-171), Online publication date: 1-Oct-2014. Pathophysiological mechanisms associated with sleep disorder breathing and their influence on treatmentSen M Indian Journal of Sleep Medicine, 10.5958/0974-0155.2014.01104.8, Vol. 9, No. 2, (50-58), Online publication date: 1-Jun-2014. Sweet Success Should Set Tongues Wagging. A Portrait of Airway Muscle Injury in Sleep ApneaO'Halloran K American Journal of Respiratory and Critical Care Medicine, 10.1164/rccm.201405-0820ED, Vol. 189, No. 11, (1299-1300), Online publication date: 1-Jun-2014. Effects of Inhaled Fluticasone on Upper Airway during Sleep and Wakefulness in Asthma: A Pilot StudyTeodorescu M, Xie A, Sorkness C, Robbins J, Reeder S, Gong Y, Fedie J, Sexton A, Miller B, Huard T, Hind J, Bioty N, Peterson E, Kunselman S, Chinchilli V, Soler X, Ramsdell J, Loredo J, Israel E, Eckert D and Malhotra A Journal of Clinical Sleep Medicine, Vol. 10, No. 02, (183-193), Online publication date: 15-Feb-2014. Edge D, McDonald F, Jones J, Bradford A and O'Halloran K Effect of Chronic Intermittent Hypoxia on the Reflex Recruitment of the Genioglossus During Airway Obstruction in the Anesthetized Rat The Central Nervous System Control of Respiration, 10.1016/B978-0-444-63274-6.00008-4, (147-168), . Respiratory Movement of Upper Airway Tissue in Obstructive Sleep ApneaBrown E, Cheng S, McKenzie D, Butler J, Gandevia S and Bilston L Sleep, 10.5665/sleep.2812, Vol. 36, No. 7, (1069-1076), Online publication date: 1-Jul-2013. Kimoff R Upper Airway Pathology Encyclopedia of Sleep, 10.1016/B978-0-12-378610-4.00304-1, (192-196), . Respiratory control and sternohyoid muscle structure and function in aged male rats: Decreased susceptibility to chronic intermittent hypoxiaSkelly J, Edge D, Shortt C, Jones J, Bradford A and O'Halloran K Respiratory Physiology & Neurobiology, 10.1016/j.resp.2011.11.004, Vol. 180, No. 2-3, (175-182), Online publication date: 1-Mar-2012. Neurogenic Changes in the Upper Airway of Patients with Obstructive Sleep ApneaSaboisky J, Stashuk D, Hamilton-Wright A, Carusona A, Campana L, Trinder J, Eckert D, Jordan A, McSharry D, White D, Nandedkar S, David W and Malhotra A American Journal of Respiratory and Critical Care Medicine, 10.1164/rccm.201106-1058OC, Vol. 185, No. 3, (322-329), Online publication date: 1-Feb-2012. Genioglossus activity available via non-arousal mechanisms vs. that required for opening the airway in obstructive apnea patientsYounes M, Loewen A, Ostrowski M, Laprairie J, Maturino F and Hanly P Journal of Applied Physiology, 10.1152/japplphysiol.00312.2011, Vol. 112, No. 2, (249-258), Online publication date: 1-Jan-2012. Sensorimotor function of the upper-airway muscles and respiratory sensory processing in untreated obstructive sleep apneaEckert D, Lo Y, Saboisky J, Jordan A, White D and Malhotra A Journal of Applied Physiology, 10.1152/japplphysiol.00653.2011, Vol. 111, No. 6, (1644-1653), Online publication date: 1-Dec-2011. Effects of loading on upper airway and respiratory pump muscle motoneuronsHill K and Eastwood P Respiratory Physiology & Neurobiology, 10.1016/j.resp.2011.04.001, Vol. 179, No. 1, (64-70), Online publication date: 1-Oct-2011. Obstructive Airway Disease and Obstructive Sleep Apnea: Effect of Pulmonary FunctionSharma B, Feinsilver S, Owens R, Malhotra A, McSharry D and Karbowitz S Lung, 10.1007/s00408-010-9270-3, Vol. 189, No. 1, (37-41), Online publication date: 1-Feb-2011. Hypoglossal nerve conduction findings in obstructive sleep apneaRamchandren S, Gruis K, Chervin R, Lisabeth L, Concannon M, Wolfe J, Albers J and Brown D Muscle & Nerve, 10.1002/mus.21690, Vol. 42, No. 2, (257-261), Online publication date: 1-Aug-2010. Differential Expression of Lipid and Carbohydrate Metabolism Genes in Upper Airway versus Diaphragm Musclevan Lunteren E, Spiegler S and Moyer M Sleep, 10.1093/sleep/33.3.363, Vol. 33, No. 3, (363-370), Online publication date: 1-Mar-2010., Online publication date: 1-Mar-2010. Uvulopalatopharyngoplasty in the Management of Obstructive Sleep Apnea: The Mayo Clinic ExperienceKhan A, Ramar K, Maddirala S, Friedman O, Pallanch J and Olson E Mayo Clinic Proceedings, 10.4065/84.9.795, Vol. 84, No. 9, (795-800), Online publication date: 1-Sep-2009. Upper airway function in the pathogenesis of obstructive sleep apnea: a review of the current literatureOwens R, Eckert D, Yeh S and Malhotra A Current Opinion in Pulmonary Medicine, 10.1097/MCP.0b013e3283130f66, Vol. 14, No. 6, (519-524), Online publication date: 1-Nov-2008. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance?Vgontzas A Archives of Physiology and Biochemistry, 10.1080/13813450802364627, Vol. 114, No. 4, (211-223), Online publication date: 1-Jan-2008. Volume 03 • Issue 06 • October 15, 2007ISSN (print): 1550-9389ISSN (online): 1550-9397Frequency: Monthly Metrics History Submitted for publicationOctober 1, 2007Accepted for publicationOctober 1, 2007Published onlineOctober 15, 2007 Information© 2007 American Academy of Sleep MedicineACKNOWLEDGEMENTSResearch from the author's laboratory cited in this article has been supported by the Canadian Institutes of Health Research, Fonds de la Recherche en Santé du Québec, Quebec Lung Association, Research Institute of the McGill University Health Centre and the Costello Fund. The author wishes to acknowledge his appreciation for the personal communication of genioglossus single motor unit electromyographic data from Dr. Simon Gandevia, and for helpful discussions with Dr. Basil Petrof concerning this manuscript.PDF download
Referência(s)